Evidence map›Paper›PMID 33888006›Full record

ReviewJournal of psychopharmacology (Oxford, England)2021

Rodent models for nicotine withdrawal.

Ranjithkumar Chellian, Azin Behnood-Rod, Dawn M Bruijnzeel, Ryann Wilson, Vijayapandi Pandy, Adriaan W Bruijnzeel

Open access · greenAbstract readReview
In one paragraph

Review in Journal of psychopharmacology (Oxford, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 48 citations in OpenAlex.

  1. The neuroimmune-glutamate hypothesis of addiction.Neuroscience and biobehavioral reviews · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Cordycepin alleviates nicotine withdrawal-induced anxietyDrug and alcohol dependence reports · 2026
    Article
  6. Article
  7. Article
  8. Prenatal Cannabis and Tobacco: Studies in Animal Models.Advances in experimental medicine and biology · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Associations of Trait Psychomotor Restlessness and Agitation With Tobacco Withdrawal Symptoms in a Nonclinical Sample of Adults Who Smoke Cigarettes.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Insights into the effect of pre- and postnatal nicotine exposure on cardiovascular development and function.American journal of physiology. Heart and circulatory physiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Ranjithkumar ChellianDepartment of Psychiatry, University of Florida, Gainesville, USA.ORCID https://orcid.org/0000-0002-2793-022X
Azin Behnood-RodDepartment of Psychiatry, University of Florida, Gainesville, USA.
Dawn M BruijnzeelDepartment of Psychiatry, University of Florida, Gainesville, USA.
Ryann WilsonDepartment of Psychiatry, University of Florida, Gainesville, USA.
Vijayapandi PandyDepartment of Pharmacology, Chalapathi Institute of Pharmaceutical Sciences, Guntur, India.
Adriaan W BruijnzeelDepartment of Psychiatry, University of Florida, Gainesville, USA.
University of Florida · USGuntur Medical College · IN

Funding

Crosstalk between dopamine and glucocorticoids in high levels of nicotine intake and anhedonia in ratsR01DA046411 · NIDA · UNIVERSITY OF FLORIDA · PI BRUIJNZEEL, ADRIAAN WILLEM · 2019 to 2024
$1.7M
Tobacco: relationship between reduced nicotine content and reinforcement in ratsR01DA042530 · NIDA · UNIVERSITY OF FLORIDA · PI BRUIJNZEEL, ADRIAAN WILLEM · 2016 to 2018
$1.1M
NIDA NIH HHS R01 DA042530NIDA NIH HHS R01 DA046411
6 · The paper itself

Abstract

backgroundAnimal models are critical to improve our understanding of the neuronal mechanisms underlying nicotine withdrawal. Nicotine dependence in rodents can be established by repeated nicotine injections, chronic nicotine infusion via osmotic minipumps, oral nicotine intake, tobacco smoke exposure, nicotine vapor exposure, and e-cigarette aerosol exposure. The time course of nicotine withdrawal symptoms associated with these methods has not been reviewed in the literature.

aimThe goal of this review is to discuss nicotine withdrawal symptoms associated with the cessation of nicotine, tobacco smoke, nicotine vapor, and e-cigarette aerosol exposure in rats and mice. Furthermore, age and sex differences in nicotine withdrawal symptoms are reviewed.

resultsCessation of nicotine, tobacco smoke, nicotine vapor, and e-cigarette aerosol exposure leads to nicotine withdrawal symptoms such as somatic withdrawal signs, changes in locomotor activity, anxiety- and depressive-like behavior, learning and memory deficits, attention deficits, hyperalgesia, and dysphoria. These withdrawal symptoms are most pronounced within the first week after cessation of nicotine exposure. Anxiety- and depressive-like behavior, and deficits in learning and memory may persist for several months. Adolescent (4-6 weeks old) rats and mice display fewer nicotine withdrawal symptoms than adults (>8 weeks old). In adult rats and mice, females show fewer nicotine withdrawal symptoms than males. The smoking cessation drugs bupropion and varenicline reduce nicotine withdrawal symptoms in rodents.

conclusionThe nicotine withdrawal symptoms that are observed in rodents are similar to those observed in humans. Tobacco smoke and e-cigarette aerosol contain chemicals and added flavors that enhance the reinforcing properties of nicotine. Therefore, more valid animal models of tobacco and e-cigarette use need to be developed by using tobacco smoke and e-cigarette aerosol exposure methods to induce dependence.

Indexed as

AnimalsDisease Models, AnimalElectronic Nicotine Delivery SystemsHumansMiceNicotineRatsSex FactorsSmoking CessationSmoking Cessation AgentsSubstance Withdrawal SyndromeTobacco Use DisorderNicotineSmoking Cessation Agentsdependencee-cigarettesmecamylamineNicotineprecipitatedsmokesmoking cessationspontaneoustobaccovaporwithdrawal

Identifiers

PMID33888006
PMCPMC8526373
OpenAlexW3153622095

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.